ID   FLCN_HUMAN              Reviewed;         579 AA.
AC   Q8NFG4; A6NJJ8; Q6ZRX1; Q96BD2; Q96BE4;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   21-MAR-2012, entry version 75.
DE   RecName: Full=Folliculin;
DE   AltName: Full=BHD skin lesion fibrofolliculoma protein;
DE   AltName: Full=Birt-Hogg-Dube syndrome protein;
GN   Name=FLCN; Synonyms=BHD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND INVOLVEMENT IN BIRT-HOGG-DUBE SYNDROME.
RC   TISSUE=Lung;
RX   MEDLINE=22193727; PubMed=12204536; DOI=10.1016/S1535-6108(02)00104-6;
RA   Nickerson M.L., Warren M.B., Toro J.R., Matrosova V., Glenn G.,
RA   Turner M.L., Duray P., Merino M., Choyke P.L., Pavlovich C.P.,
RA   Sharma N., Walther M.M., Munroe D., Hill R., Maher E., Greenberg C.,
RA   Lerman M.I., Linehan W.M., Zbar B., Schmidt L.S.;
RT   "Mutations in a novel gene lead to kidney tumors, lung wall defects,
RT   and benign tumors of the hair follicle in patients with the Birt-Hogg-
RT   Dube syndrome.";
RL   Cancer Cell 2:157-164(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 267-579 (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   POSSIBLE INVOLVEMENT IN COLORECTAL CANCER, AND VARIANTS TRP-79 AND
RP   THR-445.
RX   PubMed=12843323; DOI=10.1136/jmg.40.7.511;
RA   Kahnoski K., Khoo S.K., Nassif N.T., Chen J., Lobo G.P., Segelov E.,
RA   Teh B.T.;
RT   "Alterations of the Birt-Hogg-Dube gene (BHD) in sporadic colorectal
RT   tumours.";
RL   J. Med. Genet. 40:511-515(2003).
RN   [7]
RP   POSSIBLE INVOLVEMENT IN RENAL CELL CARCINOMA AND COLORECTAL CANCER,
RP   AND VARIANTS VAL-238; GLN-320; GLY-392 AND SER-444.
RX   PubMed=14627671; DOI=10.1136/jmg.40.11.820;
RA   da Silva N.F., Gentle D., Hesson L.B., Morton D.G., Latif F.,
RA   Maher E.R.;
RT   "Analysis of the Birt-Hogg-Dube (BHD) tumour suppressor gene in
RT   sporadic renal cell carcinoma and colorectal cancer.";
RL   J. Med. Genet. 40:820-824(2003).
RN   [8]
RP   INVOLVEMENT IN PSP.
RX   PubMed=15657874; DOI=10.1086/428455;
RA   Painter J.N., Tapanainen H., Somer M., Tukiainen P., Aittomaeki K.;
RT   "A 4-bp deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly
RT   inherited spontaneous pneumothorax.";
RL   Am. J. Hum. Genet. 76:522-527(2005).
RN   [9]
RP   INVOLVEMENT IN BIRT-HOGG-DUBE SYNDROME.
RX   PubMed=15852235; DOI=10.1086/430842;
RA   Schmidt L.S., Nickerson M.L., Warren M.B., Glenn G.M., Toro J.R.,
RA   Merino M.J., Turner M.L., Choyke P.L., Sharma N., Peterson J.,
RA   Morrison P., Maher E.R., Walther M.M., Zbar B., Linehan W.M.;
RT   "Germline BHD-mutation spectrum and phenotype analysis of a large
RT   cohort of families with Birt-Hogg-Dube syndrome.";
RL   Am. J. Hum. Genet. 76:1023-1033(2005).
RN   [10]
RP   FUNCTION, PHOSPHORYLATION, SUBCELLULAR LOCATION, INTERACTION WITH
RP   FNIP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17028174; DOI=10.1073/pnas.0603781103;
RA   Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L.,
RA   Iwamatsu A., Esposito D., Gillette W.K., Hopkins R.F. III,
RA   Hartley J.L., Furihata M., Oishi S., Zhen W., Burke T.R. Jr.,
RA   Linehan W.M., Schmidt L.S., Zbar B.;
RT   "Folliculin encoded by the BHD gene interacts with a binding protein,
RT   FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006).
RN   [11]
RP   INTERACTION WITH FNIP2.
RX   PubMed=18403135; DOI=10.1016/j.gene.2008.02.022;
RA   Hasumi H., Baba M., Hong S.-B., Hasumi Y., Huang Y., Yao M.,
RA   Valera V.A., Linehan W.M., Schmidt L.S.;
RT   "Identification and characterization of a novel folliculin-interacting
RT   protein FNIP2.";
RL   Gene 415:60-67(2008).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH FNIP2.
RX   PubMed=18663353; DOI=10.1038/onc.2008.261;
RA   Takagi Y., Kobayashi T., Shiono M., Wang L., Piao X., Sun G.,
RA   Zhang D., Abe M., Hagiwara Y., Takahashi K., Hino O.;
RT   "Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel
RT   Fnip1-like (FnipL/Fnip2) protein.";
RL   Oncogene 27:5339-5347(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62 AND SER-73, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-73 AND SER-302,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   VARIANT RCC CYS-239.
RX   PubMed=18794106; DOI=10.1158/1078-0432.CCR-08-0608;
RA   Woodward E.R., Ricketts C., Killick P., Gad S., Morris M.R.,
RA   Kavalier F., Hodgson S.V., Giraud S., Bressac-de Paillerets B.,
RA   Chapman C., Escudier B., Latif F., Richard S., Maher E.R.;
RT   "Familial non-VHL clear cell (conventional) renal cell carcinoma:
RT   clinical features, segregation analysis, and mutation analysis of
RT   FLCN.";
RL   Clin. Cancer Res. 14:5925-5930(2008).
RN   [16]
RP   VARIANTS PSP PHE-157 DEL AND TYR-429.
RX   PubMed=18505456; DOI=10.1111/j.1399-0004.2008.01030.x;
RA   Ren H.Z., Zhu C.C., Yang C., Chen S.L., Xie J., Hou Y.Y., Xu Z.F.,
RA   Wang D.J., Mu D.K., Ma D.H., Wang Y., Ye M.H., Ye Z.R., Chen B.F.,
RA   Wang C.G., Lin J., Qiao D., Yi L.;
RT   "Mutation analysis of the FLCN gene in Chinese patients with sporadic
RT   and familial isolated primary spontaneous pneumothorax.";
RL   Clin. Genet. 74:178-183(2008).
RN   [17]
RP   VARIANT PSP LYS-132.
RX   PubMed=18579543; DOI=10.1183/09031936.00132707;
RA   Frohlich B.A., Zeitz C., Matyas G., Alkadhi H., Tuor C., Berger W.,
RA   Russi E.W.;
RT   "Novel mutations in the folliculin gene associated with spontaneous
RT   pneumothorax.";
RL   Eur. Respir. J. 32:1316-1320(2008).
RN   [18]
RP   VARIANT BHD ARG-508.
RX   PubMed=18234728; DOI=10.1136/jmg.2007.054304;
RA   Toro J.R., Wei M.H., Glenn G.M., Weinreich M., Toure O., Vocke C.,
RA   Turner M., Choyke P., Merino M.J., Pinto P.A., Steinberg S.M.,
RA   Schmidt L.S., Linehan W.M.;
RT   "BHD mutations, clinical and molecular genetic investigations of Birt-
RT   Hogg-Dube syndrome: a new series of 50 families and a review of
RT   published reports.";
RL   J. Med. Genet. 45:321-331(2008).
RN   [19]
RP   VARIANT BHD ILE-108.
RX   PubMed=19785621; DOI=10.1111/j.1365-2133.2009.09517.x;
RA   Kluger N., Giraud S., Coupier I., Avril M.F., Dereure O., Guillot B.,
RA   Richard S., Bessis D.;
RT   "Birt-Hogg-Dube syndrome: clinical and genetic studies of 10 French
RT   families.";
RL   Br. J. Dermatol. 162:527-537(2010).
RN   [20]
RP   VARIANT CYS-362, AND CHARACTERIZATION OF VARIANTS PHE-157 DEL;
RP   CYS-239; CYS-362 AND ARG-508.
RX   PubMed=21538689; DOI=10.1002/humu.21519;
RA   Nahorski M.S., Reiman A., Lim D.H., Nookala R.K., Seabra L., Lu X.,
RA   Fenton J., Boora U., Nordenskjold M., Latif F., Hurst L.D.,
RA   Maher E.R.;
RT   "Birt Hogg-Dube syndrome-associated FLCN mutations disrupt protein
RT   stability.";
RL   Hum. Mutat. 32:921-929(2011).
CC   -!- FUNCTION: May play a role in the pathogenesis of an uncommon form
CC       of kidney cancer through its association with an inherited
CC       disorder of the hair follicle (fibrofolliculomas). May be a tumor
CC       suppressor. May be involved in colorectal tumorigenesis. May be
CC       involved in energy and/or nutrient sensing through the AMPK and
CC       mTOR signaling pathways. May regulate phosphorylation of RPS6KB1.
CC   -!- SUBUNIT: Interacts (via C-terminus) with FNIP1 and FNIP2 (via C-
CC       terminus). This mediates indirect interaction with the PRKAA1,
CC       PRKAB1 and PRKAG1 subunits of 5'-AMP-activated protein kinase.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Mainly localized in
CC       the nucleus. Co-localizes with FNIP1 and FNIP2 in the cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NFG4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NFG4-2; Sequence=VSP_017314, VSP_017315;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q8NFG4-3; Sequence=VSP_017312, VSP_017313;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues tested, including
CC       skin, lung, kidney, heart, testis and stomach.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal lung, kidney, liver, and
CC       brain.
CC   -!- PTM: Phosphorylated. Several different phosphorylated forms exist.
CC   -!- DISEASE: Defects in FLCN are the cause of Birt-Hogg-Dube syndrome
CC       (BHD) [MIM:135150]. BHD is a rare autosomal dominant
CC       genodermatosis characterized by hair follicle hamartomas
CC       (fibrofolliculomas), kidney tumors, and spontaneous pneumothorax.
CC       Fibrofolliculomas are part of the triad of BHD skin lesions that
CC       also includes trichodiscomas and acrochordons. Onset of this
CC       dermatologic condition is invariably in adulthood. BHD is
CC       associated with a variety of histologic types of renal tumors,
CC       including chromophobe renal cell carcinoma (RCC), benign renal
CC       oncocytoma, clear-cell RCC and papillary type I RCC. Multiple
CC       lipomas, angiolipomas, and parathyroid adenomas are also seen in
CC       patients affected with this disease. The majority of mutations are
CC       predicted to prematurely terminate the protein.
CC   -!- DISEASE: Defects in FLCN are in some cases a cause of primary
CC       spontaneous pneumothorax (PSP) [MIM:173600]. PSP is a condition in
CC       which air is present in the pleural space in the absence of a
CC       precipitating event, such as trauma or lung disease. This results
CC       in secondary collapse of the lung, either partially or completely,
CC       and some degree of hypoxia. PSP is relatively common, with an
CC       incidence between 7.4-18/100'000 for men and 1.2-6/100'000 for
CC       women and a dose-dependent, increased risk among smokers. Most
CC       cases are sporadic, typically occurring in tall, thin men aged 10-
CC       30 years and generally while at rest. Familial PSP is rarer and
CC       usually is inherited as an autosomal dominant condition with
CC       reduced penetrance, although X-linked recessive and autosomal
CC       recessive inheritance have also been suggested.
CC   -!- DISEASE: Defects in FLCN may be a cause of renal cell carcinoma
CC       (RCC) [MIM:144700]. Renal cell carcinoma is a heterogeneous group
CC       of sporadic or hereditary carcinoma derived from cells of the
CC       proximal renal tubular epithelium. It is subclassified into clear
CC       cell renal carcinoma (non-papillary carcinoma), papillary renal
CC       cell carcinoma, chromophobe renal cell carcinoma, collecting duct
CC       carcinoma with medullary carcinoma of the kidney, and unclassified
CC       renal cell carcinoma. Clear cell renal cell carcinoma is the most
CC       common subtype.
CC   -!- SIMILARITY: Belongs to the folliculin family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/FLCN";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FLCNID789ch17p11.html";
CC   -!- WEB RESOURCE: Name=Leiden Open Variation Database; Note=Folliculin
CC       (FLCN);
CC       URL="http://grenada.lumc.nl/LOVD2/shared1/home.php?select_db=FLCN";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF517523; AAM94803.1; -; mRNA.
DR   EMBL; AK127912; BAC87186.1; -; mRNA.
DR   EMBL; AK126951; BAC86760.1; -; mRNA.
DR   EMBL; AC055811; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471196; EAW55716.1; -; Genomic_DNA.
DR   EMBL; BC015687; AAH15687.1; -; mRNA.
DR   EMBL; BC015725; AAH15725.2; -; mRNA.
DR   IPI; IPI00185096; -.
DR   IPI; IPI00329635; -.
DR   IPI; IPI00444197; -.
DR   RefSeq; NP_653207.1; NM_144606.5.
DR   RefSeq; NP_659434.2; NM_144997.5.
DR   UniGene; Hs.31652; -.
DR   ProteinModelPortal; Q8NFG4; -.
DR   IntAct; Q8NFG4; 3.
DR   STRING; Q8NFG4; -.
DR   PhosphoSite; Q8NFG4; -.
DR   DMDM; 74751276; -.
DR   PRIDE; Q8NFG4; -.
DR   DNASU; 201163; -.
DR   Ensembl; ENST00000285071; ENSP00000285071; ENSG00000154803.
DR   GeneID; 201163; -.
DR   KEGG; hsa:201163; -.
DR   UCSC; uc002gra.2; human.
DR   UCSC; uc002grb.2; human.
DR   UCSC; uc002grc.2; human.
DR   CTD; 201163; -.
DR   GeneCards; GC17M017056; -.
DR   H-InvDB; HIX0202417; -.
DR   HGNC; HGNC:27310; FLCN.
DR   HPA; CAB015158; -.
DR   HPA; HPA028760; -.
DR   MIM; 135150; phenotype.
DR   MIM; 144700; phenotype.
DR   MIM; 173600; phenotype.
DR   MIM; 607273; gene.
DR   neXtProt; NX_Q8NFG4; -.
DR   Orphanet; 122; Birt-Hogg-Dube syndrome.
DR   Orphanet; 2903; Familial spontaneous pneumothorax.
DR   PharmGKB; PA134901005; -.
DR   eggNOG; NOG319853; -.
DR   GeneTree; ENSGT00390000009864; -.
DR   HOGENOM; HBG716059; -.
DR   HOVERGEN; HBG081531; -.
DR   InParanoid; Q8NFG4; -.
DR   KO; K09594; -.
DR   OMA; LLKFWMT; -.
DR   OrthoDB; EOG4P8FHW; -.
DR   PhylomeDB; Q8NFG4; -.
DR   NextBio; 90061; -.
DR   ArrayExpress; Q8NFG4; -.
DR   Bgee; Q8NFG4; -.
DR   CleanEx; HS_FLCN; -.
DR   Genevestigator; Q8NFG4; -.
DR   GermOnline; ENSG00000154803; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR021713; Folliculin.
DR   Pfam; PF11704; Folliculin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Disease mutation; Nucleus; Phosphoprotein; Reference proteome;
KW   Tumor suppressor.
FT   CHAIN         1    579       Folliculin.
FT                                /FTId=PRO_0000223940.
FT   COILED      287    310       Potential.
FT   MOD_RES      62     62       Phosphoserine.
FT   MOD_RES      73     73       Phosphoserine.
FT   MOD_RES     302    302       Phosphoserine.
FT   VAR_SEQ     134    197       CPGREGPIFFGDEQHGFVFSHTFFIKDSLARGFQRWYSIIT
FT                                IMMDRIYLINSWPFLLGKVRGII -> SLVATEPVSVGAHM
FT                                LPGALGGLGASIAQGGRHWSSLRADPQISTAQGTGRLPCPE
FT                                LREESCWTC (in isoform 3).
FT                                /FTId=VSP_017312.
FT   VAR_SEQ     198    579       Missing (in isoform 3).
FT                                /FTId=VSP_017313.
FT   VAR_SEQ     291    342       DLEEESESWDNSEAEEEEKAPVLPESTEGRELTQGPAESSS
FT                                LSGCGSWQPRK -> GEAGVLLPGPWPGWPWGGTSCLLSWQ
FT                                ESLREGNAALNQPRTSLREAHPPISV (in isoform
FT                                2).
FT                                /FTId=VSP_017314.
FT   VAR_SEQ     343    579       Missing (in isoform 2).
FT                                /FTId=VSP_017315.
FT   VARIANT      79     79       S -> W (in a sporadic colorectal
FT                                carcinoma; somatic mutation).
FT                                /FTId=VAR_025356.
FT   VARIANT     108    108       S -> I (in BHD).
FT                                /FTId=VAR_066023.
FT   VARIANT     132    132       E -> K (in PSP).
FT                                /FTId=VAR_066024.
FT   VARIANT     157    157       Missing (in PSP; impaired protein
FT                                stability).
FT                                /FTId=VAR_066025.
FT   VARIANT     238    238       A -> V (in a renal cell carcinoma cell
FT                                line).
FT                                /FTId=VAR_025357.
FT   VARIANT     239    239       R -> C (in RCC; impaired protein
FT                                stability).
FT                                /FTId=VAR_066026.
FT   VARIANT     320    320       R -> Q (in a primary colorectal cancer).
FT                                /FTId=VAR_025358.
FT   VARIANT     362    362       R -> C (found in a colorectal cell line;
FT                                impaired protein stability).
FT                                /FTId=VAR_066027.
FT   VARIANT     392    392       R -> G (in a primary colorectal cancer;
FT                                somatic mutation).
FT                                /FTId=VAR_025359.
FT   VARIANT     429    429       H -> Y (in PSP).
FT                                /FTId=VAR_066028.
FT   VARIANT     444    444       A -> S (in a primary clear-cell renal
FT                                cell carcinoma; somatic mutation).
FT                                /FTId=VAR_025360.
FT   VARIANT     445    445       A -> T (in a sporadic colorectal
FT                                carcinoma; somatic mutation;
FT                                dbSNP:rs41419545).
FT                                /FTId=VAR_025361.
FT   VARIANT     508    508       K -> R (in BHD; does not impair protein
FT                                stability, growth suppression activity or
FT                                intracellular localization of
FT                                folliculin).
FT                                /FTId=VAR_066029.
SQ   SEQUENCE   579 AA;  64473 MW;  E168EB34544C6336 CRC64;
     MNAIVALCHF CELHGPRTLF CTEVLHAPLP QGDGNEDSPG QGEQAEEEEG GIQMNSRMRA
     HSPAEGASVE SSSPGPKKSD MCEGCRSLAA GHPGYISHDK ETSIKYVSHQ HPSHPQLFSI
     VRQACVRSLS CEVCPGREGP IFFGDEQHGF VFSHTFFIKD SLARGFQRWY SIITIMMDRI
     YLINSWPFLL GKVRGIIDEL QGKALKVFEA EQFGCPQRAQ RMNTAFTPFL HQRNGNAARS
     LTSLTSDDNL WACLHTSFAW LLKACGSRLT EKLLEGAPTE DTLVQMEKLA DLEEESESWD
     NSEAEEEEKA PVLPESTEGR ELTQGPAESS SLSGCGSWQP RKLPVFKSLR HMRQVLGAPS
     FRMLAWHVLM GNQVIWKSRD VDLVQSAFEV LRTMLPVGCV RIIPYSSQYE EAYRCNFLGL
     SPHVQIPPHV LSSEFAVIVE VHAAARSTLH PVGCEDDQSL SKYEFVVTSG SPVAADRVGP
     TILNKIEAAL TNQNLSVDVV DQCLVCLKEE WMNKVKVLFK FTKVDSRPKE DTQKLLSILG
     ASEEDNVKLL KFWMTGLSKT YKSHLMSTVR SPTASESRN
//
